Who is sponsoring NCT04192084?

NCT04192084 is sponsored by Assiut University.

What drugs are being tested in NCT04192084?

Interventions in NCT04192084: microvascular partial toe transfer.

What condition does NCT04192084 study?

NCT04192084 studies Amputation, Traumatic, Hand Injuries.

Is NCT04192084 still recruiting?

NCT04192084 is currently status unknown. Last updated 10 December 2019.

Last reviewed 2019-12-10 · How we verify

NCT04192084

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Microvascular Partial Toe Transfer

Status unknown NA Last updated 10 December 2019

What this trial tests

NA trial testing microvascular partial toe transfer in Amputation, Traumatic in 20 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
1 November 2020

1 December 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 December 2019
Primary completion	1 November 2020
Estimated completion	1 December 2020

Drugs / interventions tested

microvascular partial toe transfer

Conditions studied

Amputation, Traumatic — all drugs for Amputation, Traumatic →
Hand Injuries — all drugs for Hand Injuries →

Sponsor

Assiut University

Who can join

Adults 18 to 50, any sex, with Amputation, Traumatic or Hand Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Microvascular partial toe transfer for reconstruction of traumatic amputation of the digits

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Amputation, Traumatic

Currently open trials in the same condition.

NCT06433648 — Understanding How Powered Componentry Impacts K2-Level Transfemoral Amputee Gait · NA · recruiting
NCT05297266 — Early Discovery of Ischemia After Replantation Surgery of the Extremities · NA · recruiting
NCT03400345 — Human Upper Extremity Allotransplantation: F/U Protocol · recruiting
NCT01459107 — Human Upper Extremity Allotransplantation · Phase 2 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04192084 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 10 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04192084.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing